Do Institutional Investors Hate CVS Caremark Corp (NYSE:CVS)?

CVS Health Corporation (NYSE:CVS) Logo

Sentiment for CVS Caremark Corp (NYSE:CVS)

CVS Caremark Corp (NYSE:CVS) institutional sentiment decreased to 1.11 in 2019 Q2. Its down -0.14, from 1.25 in 2019Q1. The ratio worsened, as 591 institutional investors increased and opened new stock positions, while 531 decreased and sold their equity positions in CVS Caremark Corp. The institutional investors in our partner’s database reported: 948.80 million shares, down from 969.19 million shares in 2019Q1. Also, the number of institutional investors holding CVS Caremark Corp in their top 10 stock positions increased from 24 to 32 for an increase of 8. Sold All: 90 Reduced: 441 Increased: 481 New Position: 110.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $83.27 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 17.54 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

The stock increased 0.20% or $0.12 during the last trading session, reaching $64.03. About 5.20M shares traded. CVS Health Corporation (NYSE:CVS) has declined 17.14% since September 13, 2018 and is downtrending. It has underperformed by 17.14% the S&P500.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on November, 5. They expect $1.77 EPS, up 2.31 % or $0.04 from last year’s $1.73 per share. CVS’s profit will be $2.30B for 9.04 P/E if the $1.77 EPS becomes a reality. After $1.89 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts -6.35 % negative EPS growth.

Srb Corp holds 7.81% of its portfolio in CVS Health Corporation for 1.54 million shares. Parus Finance (Uk) Ltd owns 305,330 shares or 7.62% of their US portfolio. Moreover, Colrain Capital Llc has 6.13% invested in the company for 100,225 shares. The United Kingdom-based Veritas Asset Management Llp has invested 5.7% in the stock. Twin Securities Inc., a New York-based fund reported 222,309 shares.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Ratings analysis reveals 100% of CVS Health’s analysts are positive. Out of 6 Wall Street analysts rating CVS Health, 6 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $58 while the high is $9100. The stock’s average target of $73.50 is 14.79% above today’s ($64.03) share price. CVS was included in 15 notes of analysts from March 15, 2019. UBS maintained the stock with “Buy” rating in Thursday, May 2 report. The company was maintained on Friday, March 15 by Cowen & Co. Raymond James maintained the shares of CVS in report on Thursday, April 18 with “Strong Buy” rating. The firm earned “Overweight” rating on Monday, April 29 by Morgan Stanley. The firm has “Outperform” rating given on Tuesday, August 27 by Cowen & Co.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: which released: “Here’s What Hedge Funds Think About CVS Health Corporation (CVS) – Yahoo Finance” on June 10, 2019, also with their article: “CVS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100000 of Lead Plaintiff Deadline in Class Action Lawsuit Against CVS Health Corporation – CVS – Business Wire” published on August 16, 2019, published: “Healthy Dividends: CVS-Aetna Synergies Starting To Gain Traction While The Stock Begins To Climb – Seeking Alpha” on September 08, 2019. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: and their article: “Google Photos and CVS Pharmacy Team Up to Offer Same-Day Printing at More Than 7,400 Locations Nationwide – Benzinga” published on September 12, 2019 as well as‘s news article titled: “CVS: This Is Disgusting – Seeking Alpha” with publication date: March 06, 2019.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.